Business Description
Inner Mongolia Grand Pharmaceutical Co Ltd
ISIN : CNE100003YX1
Total Employee Number:
229Compare
Compare
Traded in other countries / regions
920433.China IPO Date
2020-07-27Description
Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production, and sales of specialty medicines and general health products. The company's main business is the research and development, production of Chinese patent medicines (including ethnic medicines) and chemical preparations, and sales.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -1.05 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 5.36 | |||||
Beneish M-Score | -3.6 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.1 | |||||
3-Year FCF Growth Rate | -14.2 | |||||
3-Year Book Growth Rate | -7.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.89 | |||||
9-Day RSI | 48.34 | |||||
14-Day RSI | 49.99 | |||||
3-1 Month Momentum % | 0.85 | |||||
6-1 Month Momentum % | -17.82 | |||||
12-1 Month Momentum % | -32.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 0.59 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 358.17 | |||||
Days Sales Outstanding | 111.05 | |||||
Days Payable | 180.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -50.7 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | -0.01 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.11 | |||||
Operating Margin % | -46.83 | |||||
Net Margin % | -58.66 | |||||
EBITDA Margin % | -57.91 | |||||
FCF Margin % | -9.83 | |||||
OCF Margin % | -0.98 | |||||
ROE % | -17.37 | |||||
ROA % | -12.45 | |||||
ROIC % | -10.72 | |||||
3-Year ROIIC % | -101.03 | |||||
ROC (Joel Greenblatt) % | -16.83 | |||||
ROCE % | -16.34 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 35.26 | |||||
PS Ratio | 10.4 | |||||
PB Ratio | 3.4 | |||||
Price-to-Tangible-Book | 3.61 | |||||
EV-to-EBIT | -19.65 | |||||
EV-to-EBITDA | -19.65 | |||||
EV-to-Revenue | 11.38 | |||||
EV-to-FCF | -115.8 | |||||
Price-to-GF-Value | 1.27 | |||||
Price-to-Projected-FCF | 49.4 | |||||
Earnings Yield (Greenblatt) % | -5.09 | |||||
FCF Yield % | -0.92 | |||||
Forward Rate of Return (Yacktman) % | -32.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inner Mongolia Grand Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 118.119 | ||
| EPS (TTM) (Â¥) | -0.276 | ||
| Beta | 1.2986 | ||
| 3-Year Sharpe Ratio | 0.39 | ||
| 3-Year Sortino Ratio | 0.97 | ||
| Volatility % | 25.7 | ||
| 14-Day RSI | 49.99 | ||
| 14-Day ATR (Â¥) | 0.245183 | ||
| 20-Day SMA (Â¥) | 5.0205 | ||
| 12-1 Month Momentum % | -32.91 | ||
| 52-Week Range (Â¥) | 4.11 - 7.44 | ||
| Shares Outstanding (Mil) | 255.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inner Mongolia Grand Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inner Mongolia Grand Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.060000 Cash Dividend | 2025-05-30 | 7.95 (+3.25%) | ||
| 1.8:1 Stock Split | 2022-05-31 | 4.49 (-0.12%) |
Show
Entries
Inner Mongolia Grand Pharmaceutical Co Ltd Frequently Asked Questions
What is Inner Mongolia Grand Pharmaceutical Co Ltd(BJSE:920433)'s stock price today?
The current price of BJSE:920433 is ¥4.94. The 52 week high of BJSE:920433 is ¥7.44 and 52 week low is ¥4.11.
When is next earnings date of Inner Mongolia Grand Pharmaceutical Co Ltd(BJSE:920433)?
The next earnings date of Inner Mongolia Grand Pharmaceutical Co Ltd(BJSE:920433) is .
Does Inner Mongolia Grand Pharmaceutical Co Ltd(BJSE:920433) pay dividends? If so, how much?
Inner Mongolia Grand Pharmaceutical Co Ltd(BJSE:920433) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Inner Mongolia Grand Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers